CERE
Ameriprise’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,347,680
| Closed | -$55.1M | – | 4038 |
|
|
2024
Q2 | $55.1M | Buy |
1,347,680
+784,907
| +139% | +$32.1M | 0.01% | 756 |
|
|
2024
Q1 | $23.8M | Buy |
562,773
+557,340
| +10,258% | +$23.6M | 0.01% | 1200 |
|
|
2023
Q4 | $230K | Buy |
+5,433
| New | +$230K | ﹤0.01% | 3687 |
|